Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Basal Cell Carcinoma”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableStudy completedNCT01529450
What this trial is testing

Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors

Who this might be right for
Basal Cell Carcinoma
Anne Chang 11
Testing effectiveness (Phase 2)Ended earlyNCT02956889
What this trial is testing

To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma

Who this might be right for
Carcinoma, Basal Cell
Istituto Clinico Humanitas 14
Not applicableStudy completedNCT03836105
What this trial is testing

CemiplimAb Survivorship Epidemiology

Who this might be right for
Cutaneous Squamous Cell CarcinomaBasal Cell Carcinoma
Regeneron Pharmaceuticals 287
Post-approval studies (Phase 4)Study completedNCT03610022
What this trial is testing

Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1

Who this might be right for
Metastatic Basal Cell CarcinomaLocally Advanced Basal Cell Carcinoma
University Hospital, Bordeaux 27
Early research (Phase 1)Study completedNCT01106508
What this trial is testing

A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsRecurrent or Refractory MedulloblastomaLocally Advanced or Metastatic Basal Cell Carcinoma
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)Study completedNCT02354261
What this trial is testing

Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)

Who this might be right for
Basal Cell Carcinoma in Basal Cell Nevus Syndrome
HedgePath Pharmaceuticals, Inc. 38
Early research (Phase 1)Study completedNCT00968981
What this trial is testing

Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Who this might be right for
Solid Cancers
Genentech, Inc. 67
Early research (Phase 1)Study completedNCT03897036
What this trial is testing

Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)

Who this might be right for
Carcinoma, Basal Cell
Senhwa Biosciences, Inc. 25
Not applicableLooking for participantsNCT05463757
What this trial is testing

Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study

Who this might be right for
Basal Cell CarcinomaLocally Advanced Basal Cell CarcinomaMetastatic Basal Cell Carcinoma+8 more
Maastricht University Medical Center 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05078047
What this trial is testing

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Who this might be right for
Lung Cancer MetastaticRenal Cell CarcinomaHead and Neck Cancer+12 more
UNICANCER 646
Not applicableLooking for participantsNCT07215988
What this trial is testing

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

Who this might be right for
Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8+5 more
Ohio State University Comprehensive Cancer Center 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT04806646
What this trial is testing

Tailored Sonidegib Schedule After Complete Response in BCC

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Gruppo Oncologico del Nord-Ovest 21
Testing effectiveness (Phase 2)Study completedNCT01327053
What this trial is testing

A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Novartis Pharmaceuticals 230
Not applicableStudy completedNCT07068568
What this trial is testing

Dose-Modulated Sonidegib Therapy for Periocular Basal Cell Carcinoma

Who this might be right for
Basal Cell CancerEyelid TumorBasal Cell Carcinoma (BCC)+1 more
Federico II University 12
Testing effectiveness (Phase 2)Temporarily pausedNCT05929664
What this trial is testing

Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Who this might be right for
Locally Advanced Basal Cell CarcinomaBasal Cell Carcinoma
Thomas Jefferson University 70
Testing effectiveness (Phase 2)Looking for participantsNCT07227870
What this trial is testing

L19IL2/TNF in Patients With Basal Cell Carcinoma

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Philogen S.p.A. 92
Testing effectiveness (Phase 2)Looking for participantsNCT06344052
What this trial is testing

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Stamford Pharmaceuticals, Inc. 80
Not applicableStudy completedNCT00851253
What this trial is testing

Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Boston Medical Center 12
Not applicableApproved For MarketingNCT01160250
What this trial is testing

Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Genentech, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07227350
What this trial is testing

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Who this might be right for
Locally Advanced Basal Cell Carcinoma
Philogen S.p.A. 180
Next Page